跳至主要内容
临床试验/CTRI/2024/03/063685
CTRI/2024/03/063685招募中不适用

Role of prophylactic biliary stent in reducing the recurrence of choledocholithiasis and biliary complications after stone clearance in patients awaiting cholecystectomy - a Multicentric randomized controlled trial (stone trial).

PGIMER8 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2024年3月20日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
PGIMER
入组人数
500
试验地点
8
主要终点
To compare the biliary and pancreatic complications in the form of cholangitis, cholecystitis, biliary pancreatitis and post ERC pancreatitis between the stent and the no stent groups

研究概览

简要总结

Patients with cholelithiasis can have presence of concomitant choledocholithiasis (CDL) in upto 30%. These stones may remain asymptomatic or cause obstructive jaundice and complications like cholangitis and pancreatitis. In situations where there is a failure of CDL clearance during endoscopic retrograde cholangiography (ERC), biliary stenting is recommended to prevent complications. However, the role of prophylactic biliary stenting in situations where CDL clearance has been achieved, and the patient is awaiting cholecystectomy is debatable. One retrospective study showed benefit while a small prospective study and a retrospective study did not show benefit of prophylactic biliary stenting. We conducted a pilot randomized trial to study the role of prophylactic biliary stent in reducing CDl recurrence and biliary/pancreatic complications. In our trial the CDL recurrence rate was similar between the stent and no stent group. However, the total complication rate was significantly higher in the stent group (p-0.024). Three patients developed post ERC pancreatitis and 2 developed cholecystitis. Although, the findings of our trial were significant, however, the trial had several limitations. Amongst them important limitations were that it was single centre and the sample size of inadequate. Also, we realized that the primary outcome should be the development of complications as it is more clinically relevant in real world scenario. While asymptomatic recurrence of CDL during the follow up is just a silent event. Hence, to address the above limitations, we planned this multicenter randomized controlled trial to study the role of a prophylactic biliary stent in prevention of biliary and pancreatic complications and recurrence of stones in patients awaiting cholecystectomy after biliary stone clearance.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • Cases of cholelithiasis with concomitant choledocholithiasis in whom CBD clearance is achieved will be included.

排除标准

  • 未提供

结局指标

主要结局

To compare the biliary and pancreatic complications in the form of cholangitis, cholecystitis, biliary pancreatitis and post ERC pancreatitis between the stent and the no stent groups

时间窗: From ERC and clearance of stone in ERC till the time period of 3 months irrespective of the timing of cholecystectomy.

次要结局

  • - To compare the CDL recurrence rate between the stent and the no stent groups(-To compare the need for repeat ERC between the stent and the no stent groups)

研究者

发起方
PGIMER
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Harshal S Mandavdhare

Post Graduate Institute of Medical Education and Research

研究点 (8)

Loading locations...

相似试验

To study the effect of placing a stent versus no... | 临床试验